Altimmune, Inc.
ALT
$2.91
-$0.02-0.68%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/5/2026
-
MarketBeat
6/22/2026
-
The Cerbat Gem
6/22/2026
-
TipRanks: TheFly
6/22/2026
-
TipRanks: TheFly
6/17/2026
-
Insider Monkey
6/17/2026
-
Seeking Alpha - Healthcare
6/16/2026
-
TipRanks
6/12/2026
-
Zacks Investment Research
6/10/2026
-
SeekingAlpha
6/10/2026
-
MarketBeat
6/8/2026
-
Zacks Investment Research
6/8/2026
-
Zacks Investment Research
6/8/2026
-
Zacks Investment Research
6/5/2026
-
MarketBeat
6/5/2026
-
The Cerbat Gem
5/29/2026
-
Tickeron - Stocks
5/28/2026
-
TipRanks Financial Blog
5/28/2026
-
Globe Newswire
5/27/2026
-
Globe Newswire
5/27/2026
-
Globe Newswire
5/22/2026
-
Zacks Investment Research
5/19/2026
-
Simply Wall St
5/14/2026
-
Zacks Investment Research
5/14/2026
-
Seeking Alpha - Healthcare
5/13/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 13, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
240 654 1450
Address
910 Clopper Road
Gaithersburg, MD 20878
Gaithersburg, MD 20878
Country
Year Founded
Business Description
Sector
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon...
more